The role of the pathologist

European Journal of Cancer, Supplement

Volumn 3, Issue 3, 2005, Pages 351-359

  Quirke, Phil ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TUMOR RECURRENCE;

EID: 27344448722     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(05)80295-2     Document Type: Article

References (37)

1. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, Kearney G, and Fielding LP Histopathology reporting in large bowel cancer J Clin Pathol 34 5 1981 509 513
2. Branston LK, Greening S, and Newcombe RG The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology Eur J Cancer 38 6 2002 743 744
3. Bull AD, Biffin AH, and Mella J Colorectal cancer pathology reporting on regional audit J Clin Pathol 50 2 1997 138 142
4. http://www.rcpath.org=ersol;resources/pdf/colorectal cancer.pdf Quirke P, and Williams GT The Royal College of Pathologists. Minimum dataset for colorectal cancer histopathology reports 1998 The Royal College of Pathologists London
5. (suppl) Maughan NJ, Morris E, and Craig SC Analysis of Northern and Yorkshire Cancer Registry Data 1995-2001 J Pathol 201 2003 18A
6. Cross SS, Feeley KM, and Angel CA The effect of four interventions on the informational content of histopathology reports of resected colorectal cancers J Clin Pathol 51 1998 481 482
7. Boyle KM, Petty D, and Chalmers AG MRI assessment of the bony pelvis may help predict resectability of the rectal cancer Colorectal Dis 7 2005 232 240
8. Birbeck KF, Macklin CP, and Tiffin NJ Rates of circumferential margin involvement vary between surgeons and predict outcomes in rectal cancer surgery Ann Surg 235 4 2002 449 457
9. www.virtualpathology.leeds.ac.uk
10. Quirke P, Durdey P, Dixon MF, and Williams NS Local recurrence of rectal adenocarcinoma is caused by inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 1986 996 999
11. Ng IO, Luk IS, and Yuen ST Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathological features Cancer 71 1993 1972 1976
12. Adam IJ, Mohamdee MO, and Martin IG Role of circumferential margin involvement in the local recurrence of rectal cancer Lancet 344 1994 707 711
13. De Haas-Koch DF, Baeten CGMI, and Jager JJ Prognostic significance of radial margins of clearance in rectal carcinoma Br J Surg 83 1996 781 785
14. Wibe A, Rendedal PR, Svensson E The Norwegian Rectal Cancer Group Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer Br J Surg 89 2002 327 334
15. Nagtegaal ID, Marijnen CAM, Kranenbarg EK, Van De Velde CJH, and Van Krieken JHJM Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimetre but two millimetres is the limit Am J Surg Pathol 26 2002 350 357
16. Adam IJ, Mohamdee MO, and Martin IG Role of circumferential margin involvement in the local recurrence of rectal cancer Lancet 344 8924 1994 707 711
17. in press Marr R, Birbeck KF, and Garvican J The abdomino-perineal excision - the next challenge after total mesorectal excision Ann Surg 2005
18. Kapiteijn E, Marijnen CAM, Nagtegaal ID The Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer New Engl J Med 345 2001 638 646
19. Medical Research Council. CLASICC Randomised trial of laparoscopic surgery versus conventional open surgery in patients with colorectal cancer. Clinical protocol.
20. Guillou P, Quirke P, Thorpe H The MRC CLASICC Trial Group Short-term endpoints of conventional versus laparoscopic assisted surgery in patients with colorectal cancer (MRC CLASICC trial):multicentre, randomised controlled trial Lancet 365 2005 1718 1726
21. Medical Research Council. Colorectal Cancer Working Party: CR07 Pathology guided treatment in rectal cancer: a randomised trial comparing preoperative radiotherapy and selective postoperative chemoradiotherapy in rectal cancer. Clinical protocol.
22. Brown G, Daniels I. On behalf of the Mercury Study Group. MRI predicts tumour spread and clear margins in patients with rectal cancer. Lancet, submitted.
23. Nagtegaal ID, Van De Velde CJH, Van Der Worp E, Kapiteijn E, Quirke P, and Van Krieken JHJM The pathology review committee for the cooperative clinical investigators of the Dutch colorectal group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control J Clin Oncol 20 7 2002 1729 1734
24. Jan Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O Norwegian Rectal Cancer Group Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection Epub 2004 Jan 14 Dis Colon Rectum 47 1 2004 48 58
25. May, submitted Nagtegaal ID, Van De Velde CJH, Marijnen CAM, Van Krieken JHJM, Quirke P For the pathology review committee and the cooperative clinical investigators of the Dutch ColoRectal Cancer Group Low rectal cancer; a call for a change of approach in abdominoperineal resection J Clin Oncol 2005
26. Daniels I the MERCURY Study Group Magnetic resonance imaging of low rectal cancers: a multi-centre, multi-disciplinary European study of 285 tumours located within 6 cm of anal verge Colorectal Disease 6 Suppl 2 2004 1
27. Feb Haward RA, Morris E, Monson JR, Johnston C, and Forman D The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study Eur J Surg Oncol 31 1 2005 22 28
28. Tei TM, Stolzenburg T, Buntzen S, Laurberg S, and Kjeldsen H Use of transpelvic rectus abdominis musculocutaneous flap for anal cancer surgery Br J Surg 90 2003 575 580
29. Jun Eriksen MT, Wibe A, Syse A, Haffner J, Wiig JN Norwegian Rectal Cancer Group Norwegian Gastrointestinal Cancer Group Inadvertent perforation during rectal cancer resection in Norway Br J Surg 91 6 2004 779
30. Dworak O, Keilholtz L, and Hoffmann A Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1997 19 23
31. Bouzourene H, Bosman FT, Seelentag W, Matter M, and Coucke P Importance of tumour regression assessment in predicting outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy Cancer 94 2002 1121 1130
32. Mandard AM, Dalibard F, and Mandard JC Pathological assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathological correlations Cancer 73 1994 2680 2686
33. Rodel C, Grabenbauer GG, and Papadopoulos T Apoptosis as a cellular predictor for histopathological response to neoadjuvant radiochemotherapy in patients with rectal cancer Int J Rad Oncol Biol Phys 52 2002 294 303
34. Sauer R, Becker H, Hoyhenberger W For the German Rectal Cancer Study Group Pre-operative versus post-operative chemoradiotherapy for rectal cancer New Engl J Med 351 2004 1731 1740
35. Sebag-Montefiore D, Hingorani M, Cooper R, Chesser P. Circumferential resection margin status predicts outcome after pre-operative chemoradiation for locally advanced rectal cancer. http://www.asco.org/ac/1,003,12-002636-0018- 0036-00190010208.00.asp
36. Appendix 7 P. Quirke CORE study: Capicitabine/Oxaliplatin, Radiotherapy and excision protocol Study No. C8601. Pathological Technique Sanofi-Aventis 2002
37. Madoff RD Chemoradiotherapy for rectal cancer - when, why and how? New Engl J Med 351 2004 1790 1792